WA3: (2S,3R,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2S,3R,4S,5S,6S)-3,4,5-trihydroxy-6-({[(1-{[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({4-[({[(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]sulfanyl}tetrahydro-2H-pyran-2-yl]methyl}sulfanyl)methyl]-1H-1,2,3-triazol-1-yl}methyl)tetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]methyl}-1H-1,2,3-triazol-4-yl)methyl]sulfanyl}methyl)tetrahydro-2H-pyran-2-yl]sulfanyl}tetrahydro-2H-pyran-3,4,5-triol
WA3 is a Ligand Of Interest in 6VGF designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6VGF_WA3_B_301 | 72% | 54% | 0.104 | 0.929 | 0.63 | 1 | 2 | 6 | 0 | 0 | 100% | 0.28 |
| 6VGF_WA3_A_301 | 61% | 50% | 0.121 | 0.91 | 0.64 | 1.18 | 2 | 8 | 0 | 0 | 100% | 0.29 |
| 6VGF_WA3_D_301 | 18% | 52% | 0.164 | 0.751 | 0.61 | 1.1 | 2 | 7 | 0 | 0 | 100% | 0.3 |
| 6VGF_WA3_C_301 | 3% | 51% | 0.224 | 0.564 | 0.59 | 1.15 | 2 | 8 | 0 | 0 | 100% | 0.29 |














